Member Info for Timster

Almost like they know what they are doing and are a step ahead of the amateur chemist PI.

Enough money to get to this point, that's probably all we need:
The AVA6000 clinical data to date is looking very promising, and as we progress into the Phase 1b study and demonstrate efficacy this will open up the commercial opportunities for AVA6000 and the pre|CISION™ technology platform.

Can't wait for tomorrow's news!

It can only be the 20p placing surely?

I'm no agentb but if I were big Al I'd be hiring some ex-special forces security just I'm case big farmer decide to take him out

Why can't he love Tuesday and Thursday?

As we know big Al loves a Tuesday RNS and he's never yet arranged a meeting without MASSIVE news being announced on the day...

Fantastic news for Avacta...

Needs to be close enough to pass secret messages by shouting into the yogurt pots joined with a piece of string.

$10 billion!!! All they can afford is a licence not a buyout.

It's ok the twitterati are now including @novartis on threads, they are bound to buy out avacta now :)

ASCO massive every year, great news....

"tomorrows news"

What we getting?

Did you mean Pre|CISION or were you talking about PreCISION

AIM is a GAME

It's hard to see what could go wrong.
It works, it releases therepeutic levels of dox into fap rich tumours.
It works so pre|CISELY that there are very few side effects and they are still yet to find a maximum tolerated dose at extremely high levels of equivalent dox.

I don't think they should bother with AACR next year, unless they are announcing a cure.

**** week SP wise, matters not, long term though... We know how much a buy out could be worth and it ends with billions

Not about the science, as the great prophet, lord of the sealions will tell you...

It's bonkers really. Although there is a requirement for hard data.

There is surely no disputing what has been communicated so far. Avacta have a drug in patient trials for more than a year, being run by cancer centers in the UK and the US. They have data from these trials that a STS specialist from NY came all the way to white city to talk about.
The MHRA have allowed them to progress to a dose of 400mg if required, which would probably prove fatal in dox equivalent.
And yet the price is lower than when a brochure from medusa was "found" on the floor of a German exhibition centre.

Size /* NY opening, good news
QDEL also flying as predicted Hurstbot....

They'll be selling them off Tuesday then going into presentation.

Death spiral continues....